To the top

Page Manager: Webmaster
Last update: 9/11/2012 3:13 PM

Tell a friend about this page
Print version

A multicentre, retrospect… - University of Gothenburg, Sweden Till startsida
To content Read more about how we use cookies on

A multicentre, retrospective study of resource utilization and costs associated with glaucoma management in France and Sweden.

Journal article
Authors Bertil Lindblom
Jean-Philippe Nordmann
Eric Sellem
Enping Chen
R Gold
Werner Polland
W Williamson
Patricia Buchholz
John G Walt
Danielle Groleau
Alistair Curry
Stacy J Evans
Published in Acta ophthalmologica Scandinavica
Volume 84
Issue 1
Pages 74-83
ISSN 1395-3907
Publication year 2006
Published at Institute of Neuroscience and Physiology, Department of Clinical Neuroscience and Rehabilitation
Pages 74-83
Language en
Keywords Aged, Antihypertensive Agents, economics, Cost-Benefit Analysis, Drug Costs, Female, France, Glaucoma, Open-Angle, economics, therapy, Health Care Costs, Health Resources, economics, utilization, Humans, Intraocular Pressure, Male, Ocular Hypertension, economics, therapy, Ophthalmologic Surgical Procedures, economics, Retrospective Studies, Sweden
Subject categories Ophtalmiatrics


PURPOSE: To assess resource utilization and costs associated with glaucoma management in France and Sweden. METHODS: A total of 267 patient records (121 in France, 146 in Sweden) with diagnoses of primary open-angle glaucoma (POAG) and ocular hypertension (OH), treated medically, were reviewed for a 2-year period (beginning during 1997-99) for relevant clinical and resource utilization data. Economic data were applied to estimate treatment costs. RESULTS: The annual cost of treating glaucoma was estimated at SEK5305 (531 euro )/patient in Sweden and 390 euro/patient in France. In both countries, medication costs comprised about half of the total costs. Surgical procedures and hospitalizations represented greater proportions of total cost in France (7.0% and 9.6%, respectively) than in Sweden (3.7% and 0.6%, respectively). CONCLUSION: Medication costs represent a high proportion of total treatment costs. These findings highlight the relative importance of medical therapy and of assessing the cost-effectiveness of medications in glaucoma.

Page Manager: Webmaster|Last update: 9/11/2012

The University of Gothenburg uses cookies to provide you with the best possible user experience. By continuing on this website, you approve of our use of cookies.  What are cookies?